Core Viewpoint - The Gross Law Firm is notifying shareholders of Agilon Health, Inc. (NYSE: AGL) about a class action lawsuit due to alleged misleading statements and guidance issued by the company during a specified class period [1][3]. Group 1: Allegations - The complaint alleges that during the class period from February 26, 2025, to August 4, 2025, Agilon Health's defendants issued materially false and misleading statements [3]. - It is claimed that the defendants recklessly provided guidance for 2025 that they knew or should have known was unattainable due to significant industry challenges [3]. - The complaint also states that the defendants overstated the immediate positive financial impact from strategic actions taken to mitigate risks, leading to materially false and misleading statements regarding Agilon's business and prospects [3]. Group 2: Class Action Details - Shareholders who purchased AGL shares during the class period are encouraged to register for the class action, with a deadline for lead plaintiff appointment set for March 2, 2026 [4]. - Once registered, shareholders will be enrolled in a portfolio monitoring system to receive updates on the case's progress [4]. - Participation in the case incurs no cost or obligation for the shareholders [4]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and illegal business practices [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions that inflated stock prices [5].

New York, New York--(Newsfile Corp. - January 28, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Ardent Health, Inc. (NYSE: ARDT) between July 18, 2024 and November 12, 2025, both dates inclusive (the "Class Period"), of the important March 9, 2026 lead plaintiff deadline.SO WHAT: If you purchased Ardent Health securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency f ...

Core Insights - The job market in 2026 is expected to present significant opportunities in the health care sector, with eight of the top ten jobs projected to be health-related [1][2]. Group 1: Job Market Overview - Health care roles constitute only 11% of total jobs in the U.S., yet they account for 72% of job growth in the broader market [2]. - The most in-demand job for 2026 is cardiac medical techs, with a median salary of $133,907 per year and a 34% increase in wage growth and job postings since 2022 [3]. Group 2: Top Occupations and Salaries - The top ten jobs in health care for 2026 include: - Truck driver owner-operator: $160,000 per year - Nurse practitioner: $143,183 - Speech language pathologist: $109,431 - Licensed professional counselor: $107,812 - Licensed clinical social worker: $119,618 - Physical therapist: $110,848 - Occupational therapist: $105,580 - Radiation therapist: $115,923 - Data scientist: $115,079 [5]. Group 3: Industry Resilience - The tech sector is also showing resilience, with employment in computer and mathematical occupations remaining nearly 20% higher than pre-pandemic levels despite a 36% decline in job postings since early 2020 [4][5].

Core Viewpoint - Astrana Health Inc. experienced a significant stock decline of approximately 22% following the Centers for Medicare & Medicaid Services' proposed updates for Medicare Advantage, indicating modest payment growth in 2027 [1] Group 1: Financial Impact - The proposed changes could lead to a net average year-over-year payment increase of only 0.09%, equating to over $700 million in additional payments to Medicare Advantage plans [2] - Medicare accounts for about 61% of Astrana Health's revenue, yet the stock's decline was more pronounced compared to peers like Agilon Health Inc. and Alignment Healthcare Inc., which saw declines of about 10% and 12% respectively [4] Group 2: Company Operations - Astrana Health operates as a Management Services Organization (MSO) that provides administrative support and services to Independent Physicians Associations (IPAs) and Medical Groups [3] - The company's risk adjustment practices differ from larger payers, focusing on direct, encounter-based patient care rather than audio-only visits or standalone chart reviews, resulting in minimal exposure to the CMS's proposed risk score impacts [5] Group 3: Future Outlook - The proposed changes may enhance Astrana Health's long-term value by encouraging payers to seek fully delegated care delivery partners for better patient management and clinical documentation [6] - Astrana Health's stock is currently trading at 0.4x estimated 2027 sales and about 6x on an EV/2027 adjusted EBITDA basis, which is viewed as an attractive entry point for investors [8]

SAN DIEGO, Jan. 27, 2026 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired agilon health, inc. (NYSE: AGL) securities between February 26, 2025 and August 4, 2025. Agilon describes itself as the "trusted partner empowering physicians to transform health care in our communities." For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. What are the allegations? Robbin ...

Core Insights - HCA Healthcare reported fourth-quarter earnings of $8.01 per share, surpassing analyst expectations of $7.45, leading to a 6% increase in pre-market trading [1] - Revenue for the quarter was $19.51 billion, a 6.7% year-over-year increase, although it fell short of the forecasted $19.67 billion [1] Financial Performance - Same-facility admissions rose by 2.4% year-over-year, while equivalent admissions increased by 2.5% [2] - Revenue per equivalent admission grew by 2.9% year-over-year, indicating improved pricing trends [2] - Adjusted EBITDA increased by 10.8% to $4.11 billion, with margins expanding to 21.1% from 20.3% a year earlier [2] Future Outlook - HCA issued a positive outlook for 2026, projecting earnings between $29.10 and $31.50 per share, exceeding the analyst consensus of $27.70 [3] - The company also forecasts revenue between $76.5 billion and $80.0 billion, surpassing expectations of $75.74 billion [3]

Core Viewpoint - UnitedHealth Group Incorporated (UNH) is under close scrutiny from investors, hedge funds, and analysts, indicating its significance in the market [1]. Company Analysis - The stock of UnitedHealth Group has been covered multiple times by analysts, reflecting ongoing interest and analysis of its performance [1]. - The company has a beneficial long position in its shares, suggesting confidence in its future performance [1]. Investment Perspective - The focus on identifying great businesses at reasonable prices indicates a long-term investment strategy, which is relevant for potential investors considering UNH [1].

The Market Flipped From Nervous to Complacent. Earnings and the Fed Meeting Are a Major Test.CONCLUDED[Stock Market News From Jan. 27, 2026: S&P 500 Hits Closing High]Last Updated:--- Updated 6 hours ago# The Market Flipped From Nervous to Complacent. Earnings and the Fed Meeting Are a Major Test.By[Connor Smith]The S&P 500 hit its highest level on record on Tuesday and was within 20 points of 7000.The market benchmark rose 0.4%. It briefly set an intraday record of 6988.72 before pulling back slightly. It' ...

Company Performance - Boeing Company reported fourth-quarter revenue of $23.948 billion, a 57% increase from $15.242 billion, driven by a sharp rise in commercial deliveries, with 160 airplanes delivered in the quarter [2][3] - The revenue exceeded analyst estimates of $22.470 billion, but the company reported an adjusted loss of $1.91 per share, missing Wall Street expectations for a loss of $0.39 per share [3] Stock Movements - Boeing's stock fell 3% following the earnings report [2] - Redwire Corp shares surged 135% to $0.63 after securing a contract worth up to $151 billion for the Missile Defense Agency [9] - HCA Healthcare Inc shares rose 9% to $514.82 after reporting better-than-expected fourth-quarter adjusted EPS and raising FY25 guidance [9] - Corning Inc shares increased by 15% to $109.16 after announcing a $6 billion agreement with Meta [9] - CommVault Systems, Inc. shares dropped 35% to $84.72 following third-quarter results [9] - Twin Hospitality Group Inc shares fell 43% to $0.30 after filing for Chapter 11 [9] - FAT Brands Inc shares decreased by 43% to $0.23 after commencing Chapter 11 [9] Sector Performance - Information technology shares gained 1.3% on Tuesday, while health care stocks fell by 1% [1]

Core Insights - UnitedHealth Group Incorporated (UNH) reported fourth-quarter 2025 adjusted earnings per share (EPS) of $2.11, exceeding the Zacks Consensus Estimate of $2.09, but reflecting a 69% decline year over year [1] - Revenues increased by 12% year over year to $113.2 billion, slightly missing the consensus mark [1] Financial Performance - The quarterly earnings were supported by growth in commercial fee-based membership and strong performance in Optum Rx, although elevated medical costs and a decline in risk-based membership partially offset these positives [2] - For the full year 2025, revenues rose nearly 12% year over year to $447.6 billion, but also marginally missed the consensus estimate [3] - UnitedHealth's fourth-quarter premium reached $88.8 billion, up from $76.5 billion a year ago, but fell short of the consensus estimate of $89 billion [4] Medical Care and Operating Costs - The adjusted medical care ratio (MCR) for the fourth quarter was 91.5%, worsening by 640 basis points from the previous year and below the Zacks Consensus Estimate of 92.2% [5] - Total operating costs for the fourth quarter were $112.8 billion, a 21.3% increase year over year, exceeding the model estimate of $109.4 billion [6] Business Segments - Revenues from UnitedHealthcare, the health benefits segment, grew 17.5% year over year to $87.1 billion, but missed the Zacks Consensus Estimate of $87.3 billion [7] - Optum's revenues were $70.3 billion, up from $65.1 billion a year ago, surpassing the consensus mark of $67.6 billion [9] Financial Position - As of December 31, 2025, UnitedHealth had cash and short-term investments of $28.1 billion, down from $29.1 billion at the end of 2024 [12] - Total equity increased to $100.1 billion from $98.3 billion at the end of 2024 [13] 2026 Outlook - Management projects revenues for 2026 to exceed $439 billion, which is below the 2025 level, with adjusted EPS expected to be at least $17.75, indicating improving margins [14] - The company anticipates MCR to be around 88.8% in 2026, down from 89.1% in 2025, and expects operating cash flows to be $18 billion, a decrease from 2025 [15]